Search

Search Results
Results 62931 - 62940 of 88302 for cancer
  • News - 4 Feb 2008
    A new study from the Monell Center increases understanding of the biological mechanisms responsible for the nausea and vomiting that often afflict patients undergoing chemotherapy.
  • News - 29 Jan 2008
    A collaboration between the Universities of Bristol, Cardiff and Swansea has been awarded £5 million by the UK Clinical Research Collaboration (UKCRC) to establish a Centre of Excellence for research...
  • News - 22 Jan 2008
    The 12 Million Euro 'GEN2PHEN' project, funded by the European Commission, aims to harness the web to capture and unify genetic information that fundamentally impacts on a person's health and disease...
  • News - 21 Jan 2008
    Estimates on the number of males in the United States who will experience prostatitis during their lifetimes range up to 50 percent.
  • News - 18 Jan 2008
    In the last few years, "personalized medicine" using genetic or other molecular biology-based diagnostic tests to customize treatment for a particular patient has emerged as a powerful new tool for...
  • News - 15 Jan 2008
    Health loss caused by type 2 diabetes will more than double in Australia by 2023, as health loss from most other major causes falls, according to new research by The University of Queensland's (UQ)...
  • News - 9 Jan 2008
    According to scientists in Britain there are four golden rules to living a longer healthier life and they say people who take them onboard live on average for another fourteen years.
  • News - 7 Jan 2008
    Generation Y is becoming more complacent about the risk of melanoma and other types of skin cancer, according to a University of New South Wales (UNSW) researcher.
  • News - 3 Jan 2008
    Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its generic version of Roche...
  • News - 17 Dec 2007
    A new review article from the journal Dermatologic Therapy reveals that rituximab, a drug used to treat lymphoma, is now becoming used by dermatologists to treat various dangerous skin diseases.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.